Showing 1 - 10 of 1,256
economies are fuelling calls to contain the so-called evergreening practices of drug producers around the world. But such … exclusivity for pharmaceuticals products and evaluates safeguards against such evergreening. …
Persistent link: https://www.econbiz.de/10011311672
Influenza vaccination could be a cost-effective way to reduce costs in terms of human lives and productivity losses, but low take-up rates and vaccination unintentionally causing moral hazard may decrease its benefits. We ran a natural field experiment in cooperation with a bank in Ecuador,...
Persistent link: https://www.econbiz.de/10012842048
We analyze the effects of a vaccination program providing free flu vaccine to individuals aged 65 or more on take-up behavior and hospitalization. Using both administrative and survey data, we implement a regression discontinuity design around the threshold at age 65, and find that the effect of...
Persistent link: https://www.econbiz.de/10012826746
Nonmedical exemptions from school-entry vaccine mandates are receiving increased policy and public health scrutiny. This paper examines how expanding the availability of exemptions influences vaccination rates in early childhood and academic achievement in middle school. We leverage 2003...
Persistent link: https://www.econbiz.de/10012840993
We study the role of media reporting of alleged adverse effects of influenza vaccination on adults' (aged 50 or more) decisions to vaccinate against the flu. We exploit the diffusion of news linking suspected deaths to the vaccine, during the 2014 vaccination campaign in Italy. Using daily...
Persistent link: https://www.econbiz.de/10012824422
Vaccination represents a canonical example of externalities in economics, yet there are few estimates of their magnitudes. I estimate social and externality benefits of influenza vaccination in two settings. First, using a natural experiment, I estimate the impacts of aggregate vaccination rates...
Persistent link: https://www.econbiz.de/10012863830
In order to slow the spread of the CoViD-19 pandemic, governments around the world have enacted a wide set of policies …
Persistent link: https://www.econbiz.de/10014088090
Persistent link: https://www.econbiz.de/10003931919
This article examines a sample of German pharmaceutical firms to highlight the strategic reasons why firms participate in various intellectual property (IP) marketplaces, both proprietary (patents and copyrights) and non-proprietary (open source and non-patented technology). The obstacles that...
Persistent link: https://www.econbiz.de/10009659550
This article discusses the medical/therapeutical responses to the COVID-19 pandemic and their political economy context. First, the very quick development of several vaccines highlights the richness of the basic knowledge waiting for therapeutical exploitation. Such knowledge has largely...
Persistent link: https://www.econbiz.de/10012803399